Jaewon Khil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jaewon Khil has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Seogsong Jeong
Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Republic of Korea
2 shared publications - Batuhan Gökbulut
Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye
1 shared publication Eun Seok Kang
Department of Biomedical Informatics, Korea University College of Medicine , Seoul 02841
1 shared publication- Eun Seok Kang
Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea
1 shared publication - Hee-Ju Kang
Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea
1 shared publication - Hokyou Lee
Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Korean Circulation Journal
- Vol. 57
Nationwide Trends in the Incidence and Fatality of Acute Myocardial Infarction and Stroke in Korea, 2011–2023
Khil J, et al. Korean Circ J. 2027 ;57:e40. https://doi.org/10.4070/kcj.2026.0060
- 1 January 2027
- Published by XMLink in Korean Circulation Journal
- Vol. 57
Open AccessNationwide Trends in the Incidence and Fatality of Acute Myocardial Infarction and Stroke in Korea, 2011–2023
Khil J, et al. Korean Circ J. 2027 ;57:e40. https://doi.org/10.4070/kcj.2026.0060
- 10 February 2026
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 28 (2) , 260-268
Coexistence of atrial fibrillation and metabolic dysfunction-associated steatotic liver disease as a high-risk overlap for incident heart failure in older adults
Older adults with atrial fibrillation (AFib) face a high risk of heart failure (HF). We investigated whether the coexistence of AFib and metabolic dysfunction–associated steatotic liver disease (MASLD) and its subtypes, including MASLD with increased alcohol intake (MetALD) and alcoholic liver disease (ALD), further increases the risk of HF. Patients (aged ≥60 years) with AFib diagnosed between 2002 and 2010 were collected from the Korean National Health Insurance Service database. MASLD status was determined during 2009–2010 [fatty liver index (FLI) ≥30]. The association between MASLD and incident HF was assessed using Fine–Gray subdistribution hazard models. Participants were followed from 1 January 2011, until the occurrence of HF, death, or 31 December 2019, whichever came first. Among 7543 older adults with AFib, 3168 had MASLD, 259 had MetALD, and 159 had ALD. The presence of MASLD (subdistribution hazard ratio, 1.22; 95% CI, 1.10–1.35, P < .001), MetALD (1.36; 1.05–1.76, P = .019), and ALD (1.42; 1.03–1.97, P = .034) was associated with a higher risk of incident HF. In restricted cubic spline analyses, significant dose–response relationships were observed for both the FLI and daily alcohol consumption, each of which was associated with increased HF risk among patients with AFib. Coexistence of AFib and MASLD identifies a high-risk overlap state for incident HF in older adults. These findings highlight the importance of recognizing inflammatory liver dysfunction driven by metabolic and alcohol-related factors as a potential amplifier of HF risk in older adults with AFib. In a cohort of 7543 older adults with AFib, the coexistence of SLD was associated with an increased risk of incident HF compared with non-SLD reference participants. Relative to non-SLD, adjusted HF risk was elevated in MASLD (aSHR 1.22, 95% CI 1.10–1.35), MetALD (aSHR 1.36, 95% CI 1.05–1.76), and ALD (aSHR 1.42, 95% CI 1.03–1.97). Dose-response patterns were observed across fatty liver index, alcohol intake, and fasting serum glucose, supporting that metabolic and alcohol-related liver dysfunction jointly amplifies HF risk in older adults with AFib.
- 10 February 2026
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 28 (2) , 260-268
Coexistence of atrial fibrillation and metabolic dysfunction-associated steatotic liver disease as a high-risk overlap for incident heart failure in older adults
Older adults with atrial fibrillation (AFib) face a high risk of heart failure (HF). We investigated whether the coexistence of AFib and metabolic dysfunction–associated steatotic liver disease (MASLD) and its subtypes, including MASLD with increased alcohol intake (MetALD) and alcoholic liver disease (ALD), further increases the risk of HF. Patients (aged ≥60 years) with AFib diagnosed between 2002 and 2010 were collected from the Korean National Health Insurance Service database. MASLD status was determined during 2009–2010 [fatty liver index (FLI) ≥30]. The association between MASLD and incident HF was assessed using Fine–Gray subdistribution hazard models. Participants were followed from 1 January 2011, until the occurrence of HF, death, or 31 December 2019, whichever came first. Among 7543 older adults with AFib, 3168 had MASLD, 259 had MetALD, and 159 had ALD. The presence of MASLD (subdistribution hazard ratio, 1.22; 95% CI, 1.10–1.35, P < .001), MetALD (1.36; 1.05–1.76, P = .019), and ALD (1.42; 1.03–1.97, P = .034) was associated with a higher risk of incident HF. In restricted cubic spline analyses, significant dose–response relationships were observed for both the FLI and daily alcohol consumption, each of which was associated with increased HF risk among patients with AFib. Coexistence of AFib and MASLD identifies a high-risk overlap state for incident HF in older adults. These findings highlight the importance of recognizing inflammatory liver dysfunction driven by metabolic and alcohol-related factors as a potential amplifier of HF risk in older adults with AFib. In a cohort of 7543 older adults with AFib, the coexistence of SLD was associated with an increased risk of incident HF compared with non-SLD reference participants. Relative to non-SLD, adjusted HF risk was elevated in MASLD (aSHR 1.22, 95% CI 1.10–1.35), MetALD (aSHR 1.36, 95% CI 1.05–1.76), and ALD (aSHR 1.42, 95% CI 1.03–1.97). Dose-response patterns were observed across fatty liver index, alcohol intake, and fasting serum glucose, supporting that metabolic and alcohol-related liver dysfunction jointly amplifies HF risk in older adults with AFib.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41
Association Between Estimated Head Non-Lean Mass and the Risk of Major Mental Disorders: Nationwide Cohort Study in Korea
Kim Y, et al. J Korean Med Sci. 2026 Dec;41:e314. https://doi.org/10.3346/jkms.2026.41.e314
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41
Open AccessAssociation Between Estimated Head Non-Lean Mass and the Risk of Major Mental Disorders: Nationwide Cohort Study in Korea
Kim Y, et al. J Korean Med Sci. 2026 Dec;41:e314. https://doi.org/10.3346/jkms.2026.41.e314
- Open Access
- 24 November 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-8
The Effects of Mindfulness and Buddhist Meditation Coaching on Mental Health Outcomes in College Students
College students are vulnerable to diverse mental health disorders. We aimed to investigate whether a meditation class would be an effective means to address students’ mental health challenges. Among the college students who registered for the meditation course, 256 participants were enrolled. The meditation course was a 15-week program incorporating mindfulness meditation and Ganhwa Seon (a traditional Buddhist meditation). A questionnaire was administered twice, on the first and last class of the course, collecting information on personal characteristics and six mental health indicators. A paired t-test was used to examine whether the meditation course conferred benefit on the mental health indicators, and logistic regression analyses were run to identify factors associated with mental health outcomes. After completing the meditation course, there were significant improvements for the adult ADHD score and ego identity (p = 0.02) but not for the other outcomes. Among college students, meditation practice may have positive effects on the adult ADHD score and ego identity.
- 24 November 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-8
Open AccessThe Effects of Mindfulness and Buddhist Meditation Coaching on Mental Health Outcomes in College Students
College students are vulnerable to diverse mental health disorders. We aimed to investigate whether a meditation class would be an effective means to address students’ mental health challenges. Among the college students who registered for the meditation course, 256 participants were enrolled. The meditation course was a 15-week program incorporating mindfulness meditation and Ganhwa Seon (a traditional Buddhist meditation). A questionnaire was administered twice, on the first and last class of the course, collecting information on personal characteristics and six mental health indicators. A paired t-test was used to examine whether the meditation course conferred benefit on the mental health indicators, and logistic regression analyses were run to identify factors associated with mental health outcomes. After completing the meditation course, there were significant improvements for the adult ADHD score and ego identity (p = 0.02) but not for the other outcomes. Among college students, meditation practice may have positive effects on the adult ADHD score and ego identity.